The EU herbal products sector has come in with a mixed reaction to the UK MHRA announcement last week that the sell-through period for unregistered herbal medicines would finish on April 30 next year - some welcome the market clarity and clean-up it promises. Others point to its draconian consequences. Others want something else all together... click here to read the full article.